For instance, IGF-1 is made in the liver, hence an undiagnosed precancerous liver disease could have prevented the liver from producing normal levels of IGF-1. The study demonstrates the power of using population-level approaches to assess the extent to which risk factors apply across the entire cancer spectrum
When a patch brand cites studies on oral berberine or injectable semaglutide to support their patch product, they are borrowing evidence from a different delivery method and dose entirely
And theyre not completely wrong to be concerned Clinical studies do show that people on GLP-1 medications lose some lean muscle mass alongside body fat
Zuraikat FM, Makarem N, Redline S, Aggarwal B, Jelic S, St-Onge MP (2020) Sleep regularity and cardiometabolic heath: is variability in sleep patterns a risk factor for excess adiposity and glycemic dysregulation
J Cell Biol (2018) 217(2):45972
The less cumulative room temperature exposure, the better the potency over the life of the vial